Key result
Novel specialty balloons aim to reduce arterial dissections and bailout stenting in peripheral artery disease.
Why the study?
Percutaneous transluminal angioplasty for PAD can cause arterial dissection leading to early vessel restenosis or reocclusion, creating a need for devices that minimize dissection and bailout stenting.
Do newly-developed specialty balloon angioplasty technologies minimize arterial dissection and bailout stenting in patients with peripheral artery disease undergoing percutaneous transluminal angioplasty?
Do newly-developed specialty balloon angioplasty technologies minimize arterial dissection and bailout stenting in patients with peripheral artery disease undergoing percutaneous transluminal angioplasty?
Answers are grounded in this paper and cite their sources.
This review evaluates three novel specialty balloon technologies aimed at minimizing arterial wall distress, dissections, and bailout stenting during peripheral angioplasty to optimize long-term endovascular outcomes.
INTRODUCTION: Percutaneous transluminal angioplasty (PTA) currently remains the endovascular treatment of choice in a large percentage of patients suffering from peripheral artery disease (PAD). However, the mechanism of angioplasty itself can cause some extent of arterial dissection leading to early vessel restenosis/reocclusion. Current endovascular imaging studies have reported a higher rate of arterial dissection than previously reported in literature and advocated the correlation of dissection with poor patency. Thus, there is the need of developing devices to minimize dissection and bailout stenting. AREAS COVERED: The present review focuses on newly-developed balloon angioplasty technologies designed to minimize arterial wall distress and consequently the rate of dissections. Available literature regarding three new specialty balloons is being reviewed, highlighting their value and limitations. Authors' future perspective about the benefits of utilizing specialty balloons towards a metal free and dissection free future is also provided. EXPERT OPINION: By understanding the mechanism of angioplasty and thus developing devices which cause minimal or no arterial wall distress, the rate of dissections and bailout stenting can be minimized and long-term clinical outcomes of endovascular therapy can be optimized.
No takes yet. Share an insight, caveat, or question.
Spiliοpoulos et al. (2019) conducted a review in Peripheral artery disease (PAD). Novel specialty balloon angioplasty technologies was evaluated on Arterial dissection and bailout stenting. Newly-developed specialty balloon angioplasty technologies (3 reviewed) are designed to minimize arterial wall distress, dissection rates, and bailout stenting in peripheral artery disease.
Synapse has enriched 10 related papers. Consider them for comparative context: